ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Oscar Lambret
Centre Oscar Lambret
Centre Oscar Lambret
Brigham and Women's Hospital
Assistance Publique - Hôpitaux de Paris
Federation Francophone de Cancerologie Digestive
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Tactile Medical
AstraZeneca
Pfizer
Fred Hutchinson Cancer Center
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca
University Hospital, Akershus
Latin American Cooperative Oncology Group
University of California, San Diego
Next Biomedical Co., Ltd.
Cardiovascular and Interventional Radiological Society of Europe
H. Lee Moffitt Cancer Center and Research Institute
Centre Hospitalier Universitaire de Nīmes
Incyte Corporation
Adaptimmune
Centre Paul Strauss
Tongji University
Pfizer
University of California, San Diego
Boehringer Ingelheim
Artios Pharma Ltd
Novartis
Rigshospitalet, Denmark
Pierre Fabre Medicament
University Health Network, Toronto
Meryx, Inc.
University of Pittsburgh
Eli Lilly and Company
Massachusetts General Hospital
Akamis Bio
Adaptimmune
Indiana University
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Tesaro, Inc.
Institut Curie
Genmab
Assistance Publique - Hôpitaux de Paris
Hospices Civils de Lyon
University of Kentucky